BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 7983392)

  • 1. Oral zinc therapy in recurrent erythema nodosum leprosum: a clinical study.
    Mahajan PM; Jadhav VH; Patki AH; Jogaikar DG; Mehta JM
    Indian J Lepr; 1994; 66(1):51-7. PubMed ID: 7983392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral zinc in recurrent Erythema Nodosum Leprosum reaction.
    Mathur NK; Bumb RA; Mangal HN
    Lepr India; 1983 Jul; 55(3):547-52. PubMed ID: 6656212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
    de Carsalade GY; Achirafi A; Flageul B
    Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum zinc/copper ratio in subtypes of leprosy and effect of oral zinc therapy on reactional states.
    George J; Bhatia VN; Balakrishnan S; Ramu G
    Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):20-4. PubMed ID: 2030313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M; Berhe D
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
    Feuth M; Brandsma JW; Faber WR; Bhattarai B; Feuth T; Anderson AM
    Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of azathioprine in preventing recurrences in a patient of recurrent erythema nodosum leprosum.
    Verma KK; Srivastava P; Minz A; Verma K
    Lepr Rev; 2006 Sep; 77(3):225-9. PubMed ID: 17172003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for erythema nodosum leprosum.
    Manandhar R; LeMaster JW; Roche PW
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):270-8. PubMed ID: 10575406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulsed corticosteroid therapy in patients with chronic recurrent ENL: a pilot study.
    Girdhar A; Chakma JK; Girdhar BK
    Indian J Lepr; 2002; 74(3):233-6. PubMed ID: 12708702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of erythema nodosum leprosum].
    Nguyen VU
    Ann Dermatol Venereol; 1994; 121(2):194-6. PubMed ID: 7979039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentoxifylline in the treatment of erythema nodosum leprosum.
    De Carsalade GY; Achirafi A; Flageul B
    J Dermatol; 2003 Jan; 30(1):64-8. PubMed ID: 12598712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of recurrent erythema nodosum leprosum with infliximab.
    Faber WR; Jensema AJ; Goldschmidt WF
    N Engl J Med; 2006 Aug; 355(7):739. PubMed ID: 16914716
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative efficacy of thalidomide and prednisolone in the treatment of moderate to severe erythema nodosum leprosum: a randomized study.
    Kaur I; Dogra S; Narang T; De D
    Australas J Dermatol; 2009 Aug; 50(3):181-5. PubMed ID: 19659979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed-type hypersensitivity reactions followed by erythema nodosum leprosum.
    Rea TH; Sieling PA
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):316-27. PubMed ID: 9934358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some unusual type 2 reactions in leprosy.
    Ramesh V; Pahwa M
    Int J Dermatol; 2010 Feb; 49(2):172-5. PubMed ID: 20465641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India.
    Pocaterra L; Jain S; Reddy R; Muzaffarullah S; Torres O; Suneetha S; Lockwood DN
    Am J Trop Med Hyg; 2006 May; 74(5):868-79. PubMed ID: 16687695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythema leprosum--after treatment of Lepromatous Leprosy.
    Eickelmann M; Steinhoff M; Metze D; Tomimori-Yamashita J; Sunderkötter C
    J Dtsch Dermatol Ges; 2010 Jun; 8(6):450-3. PubMed ID: 19922466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythema nodosum leprosum in subgroups of lepromatous leprosy.
    Bhargava P; Kuldeep CM; Mathur NK
    Lepr Rev; 1997 Dec; 68(4):373-5. PubMed ID: 9503874
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation between TNF production, increase of plasma C-reactive protein level and suppression of T lymphocyte response to concanavalin A during erythema nodosum leprosum.
    Foss NT; de Oliveira EB; Silva CL
    Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):218-26. PubMed ID: 8371031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.